January 13, 2025CureusOpen Access

Wearables and Atrial Fibrillation: Advances in Detection, Clinical Impact, Ethical Concerns, and Future Perspectives

Q: What is the clinical evidence from this study?

Study design: Review. Population: Atrial fibrillation. Intervention: Wearable devices (smartwatches and fitness bands).

View Full Paper

Ask AI

Bookmark

Key result

Wearable devices enable early, non-invasive AFib detection in high-risk asymptomatic individuals.

Why the study?

Although AI algorithms in wearables can identify AF, critical questions remain regarding their integration into clinical practice, ethical implications, and long-term benefits.

Do wearable devices with AI-enabled algorithms accurately detect atrial fibrillation compared to standard clinical methods?

Structured PICO

Do wearable devices with AI-enabled algorithms accurately detect atrial fibrillation compared to standard clinical methods?

Population

Individuals at risk for or with a history of atrial fibrillation

Intervention

Wearable devices (smartwatches, fitness bands, smartphones) using artificial intelligence algorithms (photoplethysmography or single-lead ECG) for atrial fibrillation detection

Comparator

Standard 12-lead ECG, Holter monitoring, or physician interpretation

Outcome

Diagnostic accuracy (sensitivity and specificity) for atrial fibrillation detection

Wearable devices offer a promising, accessible method for early detection of atrial fibrillation, but their integration into clinical practice requires addressing ethical, regulatory, and real-world accuracy challenges.

Limitations

Lack of clear legal and regulatory frameworks for data rights and privacy
Devices considered low-risk do not undergo a formal FDA approval process
Decisions are often ill-informed as smartwatches do not provide information equivalent to formal medical counseling
Most studies evaluating these devices were developed in high-income countries, raising health equity concerns
Smartwatches are predominantly used by young, white individuals with higher socioeconomic status
Many technologies have not yet undergone rigorous clinical validation
Lack of clear legal and regulatory frameworks for data rights and security
Devices bypass rigorous scientific validation as they do not undergo formal FDA approval for medical devices
AI algorithms may be biased, having been tested predominantly in high-income countries on young, white individuals with higher socioeconomic status
Risk of false-positive or false-negative results without formal medical counseling
Routine use may lead to increased demand for services, placing additional stress on healthcare providers

Implication

Should not yet change AF screening practice; leaves open need for prospective validation of accuracy and integration.

Abstract

Atrial fibrillation (AF), the most common cardiac arrhythmia, is associated with a significantly increased risk of stroke, heart failure, and mortality. Early diagnosis and management are crucial to mitigating these risks. Wearable devices such as smartwatches and fitness bands, enhanced by advanced artificial intelligence (AI) algorithms, offer a promising solution for early AF detection due to their accessibility, ease of use, and cost-effectiveness. Although the ability of these algorithms to identify AF has been authorized, critical questions remain about their integration into clinical practice, ethical implications, and long-term benefits. This review uniquely explores the intersection of wearable technology and AF management, providing a detailed analysis of current evidence, emerging trends, and the challenges associated with these innovations.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Francisco et al. (2025) conducted a review in Atrial fibrillation. Wearable devices (smartwatches and fitness bands) was evaluated. Wearable devices such as smartwatches and fitness bands offer a non-invasive, easy-to-use tool for the early detection of atrial fibrillation, especially in high-risk asymptomatic individuals.

synapsesocial.com/papers/6a17c379aeefdf6d9c12f2ac https://doi.org/10.7759/cureus.77404